MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » FDA clears Abbott’s wireless handheld testing system | Regulatory roundup

FDA clears Abbott’s wireless handheld testing system | Regulatory roundup

By

Clearances roundup

The FDA granted Abbott Laboratories (NYSE:ABT) 510(k) clearance for the wireless version of its i-STAT 1 point of care testing system.

Healthcare providers use the Abbott Park, Ill.-based company’s handheld i-STAT 1 device to transmit diagnostic test results from the patient directly to electronic health records where doctor can access the data.

"With wireless, physicians can receive immediate test information in the electronic medical record, enabling them to act quickly when a patient’s clinical status is rapidly changing," head of Abbott POC business Greg Arnsdorff said in prepared remarks.

Abbott said its 10-minute i-STAT cardiac troponin test cartridge, which gives emergency department staff the ability to test, transmit and treat potential heart attack patients from the bedside, is one example of the system’s POC capabilities for increasing the pace of care.

About 50,000 i-STAT devices are in use worldwide and they process about 100 million test cartridges a year, according to the company.

Here’s a roundup of companies announcing clearances and approvals from the Food & Drug Administration and foreign regulatory agencies. Check out MassDevice’s compilation of the latest regulatory news for additional clearances and approvals.

  • Carl Zeiss Meditec wins PMA for expanded laser treatments
    Carl Zeiss Meditec Inc.’s MEL 80 Excimer Laser won pre-market approval from the FDA for the treatment of hyperopia. This new indication complements the existing FDA approved applications of the surgical laser for myopia and astigmatism.
    Read more

  • Access Scientific wins FDA clearance for Powerwand
    Access Scientific Inc. received FDA 510(k) clearance for the Powerwand — an extended-dwell, power-injectable 3.1 inch IV catheter delivered by means of the wands’s Accelerated Seldinger Technique. The device is designed to "transform the in-patient experience, by allowing many if not most patients to have one and only one needlestick for vascular access throughout their hospitalization," according to the company.
    Read more

  • EnteroMedics wins CE Mark approval for Maestro RC system
    EnteroMedics Inc. (NSDQ:ETRM) received CE Mark approval of its second generation Maestro RC System for the treatment of obesity using VBLOC vagal blocking therapy. The Maestro RC System, a pacemaker-like device, is designed to offer a patient-oriented obesity therapy that affects the physiology of hunger and fullness without forcing punitive, mechanical limits to lifestyle and diet, or requiring surgical alteration of the anatomy. The company plans to commercialize the Maestro RC System in Australia.
    Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Reflow Medical launches low-profile reinforced support catheters
    Reflow Medical today announced it has launched its Reflow Spex Low Profile reinforced support catheters. The Spex LP catheters are designed to provide the lowest profile tip to access and cross the tightest and most complex lesions with a supportive system. They come in 0.014 in. and 0.018 in. sizes and can be combined with… […]
  • CDER head Woodcock to lead FDA for now
    FDA veteran Dr. Janet Woodcock has been tapped as interim FDA commissioner by the Biden administration, according to published reports. An article by BioCentury also said that former FDA commissioner David Kessler, who had been mentioned as a possible replacement for current commissioner Stephen Hahn, will be a consultant to the agency but will not… […]
  • What’s next for the FDA and for Stephen Hahn?
    Outgoing FDA commissioner Stephen Hahn says he needs some time to reflect on his future after leading the FDA for a little over a year. It’s hard to blame him. Hahn’s brief tenure at FDA has been rocky, to say the least. (News of his temporary replacement broke on Thursday, when the incoming Biden administration… […]
  • Medicare to cover breakthrough devices
    FDA-designated breakthrough devices will have Medicare coverage the same day they are approved, under a final rule issued this week by the Centers for Medicare and Medicaid Services (CMS). The Medicare Coverage of Innovative Technology (MCIT) rule will provide national Medicare coverage as early as the same day as FDA market authorization for breakthrough devices… […]
  • FDA debuts plan for AI-based Software as a Medical Device
    The FDA today released its first plan to regulate artificial intelligence/machine learning (AI/ML)-based Software as a Medical Device (SaMD). The plan is a response to feedback received from the agency’s April 2019 discussion paper, “Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning-Based Software as a Medical Device.” It outlines five actions that the FDA… […]
  • EU allows remote audits for medical devices during pandemic
    The European Union has announced that it will temporarily allow remote audits of medical devices and in vitro diagnostics under the new regulations (MDR IVDR), set to go into effect on May 2021 and 2022 respectively. In a document published Monday, the European Commission agreed with industry and notified bodies that the ongoing COVID-19 pandemic… […]
  • Apple magnetic charger, smartwatch may deactivate Medtronic ICD
    A new study in the Heart Rhythm Journal showed a magnetic charger for the iPhone 12 was able to deactivate a Medtronic implantable cardioverter defibrillator (ICD). The iPhone 12 has a circular array of magnets deployed around a central charging coil, making it compatible with the company’s wireless “MagSafe” accessories, according to the study published… […]
  • BREAKING: Steris to acquire Cantel Medical in $4.6B deal
    Steris (NYSE:STE) announced today that it will acquire Cantel Medical (NYSE:CMD) for $4.6 billion — a major merger in the infection prevention space. The deal is expected to close by June 30, pending customary closing conditions, regulatory approvals and an OK by Cantel shareholders. News of the merger comes a month and a half after Steris closed… […]
  • How Abbott stayed two steps ahead of COVID-19
    Developing a fast COVID-19 that resembled a pregnancy test and building two factories to boost productions — those were but two of the quick-thinking actions that Abbott (NYSE:ABT) officials took in the early months of a deadly coronavirus pandemic. Abbott began tracking the virus in China at the end of 2019 and into early 2020. By February,… […]
  • BREAKING: Big medtech suspends political contributions in wake of Electoral College vote
    Just as they lined up to condemn last week’s attack on the U.S. Capitol, major medtech companies are suspending political contributions because of 147 federal lawmakers’ refusal to acknowledge the Electoral College win by President-elect Joe Biden and Vice President-elect Kamala Harris. Boston Scientific announced on Sunday that it has chosen to temporarily suspend its… […]
  • Neurofeedback could help prostheses feel lighter: Here’s how
    Researchers at ETH Zurich have developed a prosthesis system that connects to the body’s nervous system to help amputees perceive a prosthetic weight as lower. The prosthesis system provides feedback to the wearer using electrodes implanted in the thigh that are connected to the leg nerves. Information from the tactile sensors under the sole of… […]

Leave a Reply